AmpliPhi BioSciences appointed Wendy Johnson to its Board of Directors
– USA, VA / SLOVENIA / AUSTRALIA – AmpliPhi BioSciences Corporation (OTCBB: APHB), the global leader in the development of bacteriophage-based antibacterial therapies to treat drug resistant infections, announced today that Wendy Johnson has been appointed to its Board of Directors effective May 19, 2014.…